" class="no-js "lang="en-US"> Wayne Hancock - Medtech Alert
Sunday, September 07, 2025
Wayne Hancock

Wayne Hancock

About Wayne Hancock

Dr. Wayne Hancock is a professor of pathology and laboratory medicine at The Perelman School of Medicine at the University of Pennsylvania. He leads a multidisciplinary team focused on improving the outcomes of organ transplantation.

Dr. Hancock’s group undertakes both clinical and basic science studies, and has expertise in multiple areas of transplant immunobiology. They are currently undertaking studies of the effects of standard immunosuppression on regulatory T cells in liver transplant recipients, and are developing approaches involving histone deacetylase inhibitors to stabilize and boost the function of these Treg cells in transplant recipients.

Related Story

Philadelphia-based Biotech Company AUM LifeTech Awarded $400,000 NCI/NIH Grant to Advance Their Lung Cancer Immunotherapy Program Using RNA-Targeting Gene Therapy with Checkpoint Inhibitors

August 18 2022

AUM LifeTech, Inc., a Philadelphia-based preclinical stage biotechnology company, has received a Small Business Innovation Research […]